After the Lykos debacle, what’s next for psychedelic therapies?
After the turbulent reaction to Lykos Therapeutics’ failure to get its MDMA formulation approved, clinicians and industry leaders working with…
Analysis
Into the unknown: How quickly can vaccines be developed for Disease X
Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina, US
Prodrugs and patents: Enhancing therapy adherence and reducing side effects
Applied Pharmaceutical Innovation’s Critical Medicines Production Centre, Canada
Are PBMs to blame for high drug prices in the US?
The most expensive drugs in the US
Pharmascience Injectable Manufacturing Facility Expansion, Quebec, Canada
